HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice. - Institut Pasteur Access content directly
Journal Articles Proceedings of the National Academy of Sciences of the United States of America Year : 2013

HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.

Olivier Schwartz
  • Function : Author
  • PersonId : 999827

Abstract

Effective control of HIV-1 infection in humans is achieved using combinations of antiretroviral therapy (ART) drugs. In humanized mice (hu-mice), control of viremia can be achieved using either ART or by immunotherapy using combinations of broadly neutralizing antibodies (bNAbs). Here we show that treatment of HIV-1-infected hu-mice with a combination of three highly potent bNAbs not only resulted in complete viremic control but also led to a reduction in cell-associated HIV-1 DNA. Moreover, lowering the initial viral load by coadministration of ART and immunotherapy enabled prolonged viremic control by a single bNAb after ART was withdrawn. Similarly, a single injection of adeno-associated virus directing expression of one bNAb produced durable viremic control after ART was terminated. We conclude that immunotherapy reduces plasma viral load and cell-associated HIV-1 DNA and that decreasing the initial viral load enables single bNAbs to control viremia in hu-mice.

Keywords

Dates and versions

pasteur-01109449 , version 1 (26-01-2015)

Identifiers

Cite

Joshua A Horwitz, Ariel Halper-Stromberg, Hugo Mouquet, Alexander D Gitlin, Anna Tretiakova, et al.. HIV-1 suppression and durable control by combining single broadly neutralizing antibodies and antiretroviral drugs in humanized mice.. Proceedings of the National Academy of Sciences of the United States of America, 2013, 110 (41), pp.16538-43. ⟨10.1073/pnas.1315295110⟩. ⟨pasteur-01109449⟩
375 View
0 Download

Altmetric

Share

Gmail Mastodon Facebook X LinkedIn More